OSI-906 (linsitinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OSI-906 (linsitinib), covering 2024-11-20 to 2024-11-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma [Phase 3]